Surgical Science Q1 2024: Soft streak continues
Research Update
2024-05-16
07:00
Redeye updates its estimates following Surgical Science’s Q1 2024 report, which came in considerably below our estimates due to weak Educational Products sales. In contrast, Industry/OEM exceeded our estimates. Despite strong comparables, Educational Products’ weakness surprised us. We lower our estimates for the segment and valuation.
CB
Christian Binder
Analyst Q&A
Closed
Christian Binder answered 2 questions.
Disclosures and disclaimers